Gerson

medicine

Stan Gerson to continue as CWRU School of Medicine’s interim dean through summer 2022

Stan Gerson, interim dean for the Case Western Reserve University School of Medicine, will continue in his term through June 30, 2022, according to a news release.

CWRU’s interim president, Scott Cowen, and provost Ben Vinson III announced the one-year extension on Tuesday, Oct. 20.

“We knew Stan’s deep familiarity with the medical school and its hospital partners would give him distinct advantages as he started in this role,” Cowen said in a provided statement. “But his ability to apply them in such an engaging and inclusive way has far exceeded even our heightened expectations. We are delighted he will helm the school throughout the 2021-2022 academic year.”

Gerson is a Distinguished University Professor and longtime director of the Case Comprehensive Cancer Center (CCCC), a consortium including CWRU, Cleveland Clinic and University Hospitals.

Gerson accepted the interim role after now-president emerita Barbara R. Snyder announced she would step down to lead the Association of American Universities starting Oct. 1. Gerson had been serving as co-chair for the university’s search for a new medical school dean, but Snyder and Vinson decided her successor should get to choose the next permanent dean, given that the medical school is responsible for about 80% of the university’s research and 43% of its revenues, according to the release. Pamela B. Davis, who previously held the dean title, announced in 2018 her plans to step back from that role and rejoin the faculty.

“Once we decided to appoint an interim dean, Stan quickly emerged as a top choice,” Vinson said in a provided statement. “Not only is he a renowned researcher in his own right, but he also has helped elevate our cancer center to distinguished prominence, making it among the nation’s most highly regarded programs.”

While serving as interim dean and with support from his leadership team, Gerson is continuing to lead the CCCC, which in 2018 received a $31.9 million grant and the highest possible rating from the National Cancer Institute. It has 400 investigators across the three institutions and supports roughly 15,000 people newly diagnosed with cancer each year, according to the release.

“I am honored by the confidence that the interim president and provost have shown in me by awarding this extension and look forward to continuing to work with our faculty, staff, students and hospital partners to advance education, research and our community’s well-being during the next 20 months,” Gerson said in a provided statement.

Source Article

Read More